Literature DB >> 10662815

First description of germline mosaicism in familial hypertrophic cardiomyopathy.

J F Forissier1, P Richard, S Briault, C Ledeuil, O Dubourg, B Charbonnier, L Carrier, C Moraine, G Bonne, M Komajda, K Schwartz, B Hainque.   

Abstract

Familial hypertrophic cardiomyopathy is a genetically and phenotypically heterogeneous disease caused by mutations in seven sarcomeric protein genes. It is known to be transmitted as an autosomal dominant trait with rare de novo mutations.A French family in which two members are affected by hypertrophic cardiomyopathy was clinically screened with electrocardiography and echocardiography. Genetic analyses were performed on leucocyte DNA by haplotype analysis with microsatellite markers at the MYH7 locus and mutation screening by single strand conformation polymorphism analysis. Two subjects exhibited severe hypertrophic cardiomyopathy. A mutation in the MYH7 gene was found in exon 14 (Arg453Cys). The two affected patients were carriers of the mutation, which was not found in the circulating lymphocytes of their parents. Haplotype analysis at the MYH7 locus with two intragenic microsatellite markers (MYOI and MYOII) and the absence of the mutation in the father's sperm DNA suggested that the mutation had been inherited from the mother. However, it was not found in either her fibroblasts or hair. This is the first description of germline mosaicism shown by molecular genetic analysis in an autosomal dominant disorder and more especially in hypertrophic cardiomyopathy. This mosaicism had been inherited from the mother but did not affect her somatic cells. Such a phenomenon might account for some de novo mutations in familial hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10662815      PMCID: PMC1734529          DOI: 10.1136/jmg.37.2.132

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands.

Authors:  I Christiaans; E A Nannenberg; D Dooijes; R J E Jongbloed; M Michels; P G Postema; D Majoor-Krakauer; A van den Wijngaard; M M A M Mannens; J P van Tintelen; I M van Langen; A A M Wilde
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

Review 2.  Cardiac troponin mutations and restrictive cardiomyopathy.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto; David Dweck; James D Potter
Journal:  J Biomed Biotechnol       Date:  2010-06-08

3.  A clinico-genetic study of renal coloboma syndrome in children.

Authors:  Hae Il Cheong; Hee Yeon Cho; Jeong Hun Kim; Young Suk Yu; Il Soo Ha; Yong Choi
Journal:  Pediatr Nephrol       Date:  2007-05-31       Impact factor: 3.714

4.  A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome.

Authors:  Barbara Zapała; Teresa Płatek; Iwona Wybrańska
Journal:  Ann Hum Genet       Date:  2015-03-16       Impact factor: 1.670

Review 5.  Sperm mosaicism: implications for genomic diversity and disease.

Authors:  Martin W Breuss; Xiaoxu Yang; Joseph G Gleeson
Journal:  Trends Genet       Date:  2021-06-19       Impact factor: 11.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.